Preparation, characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model.
about
Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentOxcarbazepine-loaded polymeric nanoparticles: development and permeability studies across in vitro models of the blood-brain barrier and human placental trophoblast.Progress and future of in vitro models to study translocation of nanoparticles.Transport of digoxin-loaded polymeric nanoparticles across BeWo cells, an in vitro model of human placental trophoblast.Therapeutic and safety considerations of nanoparticle-mediated drug delivery in pregnancy.Preventing female virilisation in congenital adrenal hyperplasia: The controversial role of antenatal dexamethasone.Nanoparticle transport across the placental barrier: pushing the field forward!Cryo-electron microscopy and cryo-electron tomography of nanoparticles.Placental control of drug delivery.Development and optimization of quercetin-loaded PLGA nanoparticles by experimental design.Current understanding of the toxicological risk posed to the fetus following maternal exposure to nanoparticles.Impact of particle size and surface modification on gold nanoparticle penetration into human placental microtissues.The Potential of Nanotechnology in Medically Assisted Reproduction.Dendritic polyglycerol nanoparticles show charge dependent bio-distribution in early human placental explants and reduce hCG secretion.An advanced human in vitro co-culture model for translocation studies across the placental barrier.Studying nanoparticle interaction with human placenta: Festina lente!Engineered nanomaterial applications in perinatal therapeutics.
P2860
Q26766128-030DDA6F-FE3A-4F5A-9CAF-66213787BDC3Q35185771-A9BF27D5-31ED-43C3-9902-8ED9DDB088A3Q36001471-C1825272-2A32-48EC-913B-A753689FC2B4Q37158671-AE24A79D-CAA2-4601-8F30-B31CF46D2E18Q38555085-C6735917-9FE9-4D70-A1FF-18EACE16FC07Q38667760-5E1CB1E4-81BC-4AD0-A750-BE23B94211F9Q38775827-D50B790D-F8CB-45FC-ABF2-3E1D084220F3Q38875362-F4FD6A71-5F53-48AA-AF3D-F6DB2795D97FQ38928337-93AA72D5-4E05-4A03-A0C7-97E645ED0E58Q43245104-D3D3A21A-1FF3-4BB6-AC0F-D1A94A5A2E87Q46271840-BA2897FB-111C-48FB-AEFD-F94B4D18B057Q47217573-8C1571DB-30BF-4993-9A6B-0B9B70B7AA27Q47708723-8D54B1E7-3C0D-4900-A590-846558D05980Q50046151-7BC7D66F-1058-4866-B692-C5156B474851Q52620795-9BECE7C0-1FE1-4DFE-AE49-2F4DA493EC4FQ54514880-94F99F15-8E06-4423-8F61-D8071BAA324AQ55058004-8B8C4ECB-6FCF-4011-911F-BFF1E0F1C255
P2860
Preparation, characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Preparation, characterization, ...... uman placental in vitro model.
@en
Preparation, characterization, ...... uman placental in vitro model.
@nl
type
label
Preparation, characterization, ...... uman placental in vitro model.
@en
Preparation, characterization, ...... uman placental in vitro model.
@nl
prefLabel
Preparation, characterization, ...... uman placental in vitro model.
@en
Preparation, characterization, ...... uman placental in vitro model.
@nl
P2093
P2860
P1476
Preparation, characterization, ...... uman placental in vitro model.
@en
P2093
Erik Rytting
Irina Kalashnikova
Mark Andrew White
Michael Sherman
P2860
P304
P356
10.1016/J.IJPHARM.2013.07.010
P407
P577
2013-07-12T00:00:00Z